After that, high ASB16-AS1 expression has been confirmed to be related to the tumor progression of glioma, non-small cell lung cancer, renal clear cell carcinoma, hepatocellular carcinoma, cervical cancer, esophageal cancer and gastric cancer [25–27]. Here, ASB16 is linked to non-small cell lung carcinoma.